Tennor Therapeutics Suzhou Ltd.

Tennor Therapeutics Suzhou Ltd.

Tennor Therapeutics Suzhou Ltd.

Date Founded



Room 711,218 Xinghu Street Building B2,SuZhou Industial Park,Suzhou, Jiangsu 215123

Type of Company



Holding Companies

Company Description

Tennor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China.

Board of Directors

Director at Arbor Pharmaceuticals LLC

Founder at E2M Partners LLC

Founding Partner at 6 Dimensions Capital

Chief Executive Officer & Founding Partner at Eight Roads Capital Advisors (Hong Kong) Ltd.

Founding Managing Partner at Northern Light Venture Capital Development Ltd.

Paths to Tennor Therapeutics Suzhou Ltd.
Potential Connections via
Relationship Science
Tennor Therapeutics Suzhou Ltd.
Details Hidden

With total assets of 10 billion yuan and managing over 22-billion-yuan funds, Suzhou Oriza Holdings focuses on equity investment (EI), debt financing, and EI services. It takes people as the most valuable assets and has established a comprehensive HR management system through continuous efforts during past decade, finally achieving a high-quality and effective young workforce.

Details Hidden

6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT.

Details Hidden

NLVCDL is a hands-on manager which focuses on early- and expansion-stage businesses in the technology, media, telecommunications, services and consumer products sectors, primarily in China, but they also invest in Korea. Their technology investment themes include innovations in the IT sector and vertical industries where technology plays a key role. In the consumer-related sector, they target capital-efficient companies offering products or services for the expanding Chinese middle class. They also have a particular interest in China-based companies addressing the global market.The firm follows a hands-on investment approach and actively promotes the growth of their portfolio companies through the provision of advisory consulting, strategic support and introductions to potential business partners. Their exit strategies include listing on the NASDAQ stock exchange.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tennor Therapeutics Suzhou Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tennor Therapeutics Suzhou Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Tennor Therapeutics Suzhou Ltd..